vs

Side-by-side financial comparison of Carnival (CCL) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.

Carnival is the larger business by last-quarter revenue ($6.3B vs $5.5B, roughly 1.2× Fresenius Medical Care AG). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 6.6%, a 1.3% gap on every dollar of revenue. On growth, Carnival posted the faster year-over-year revenue change (6.6% vs -0.3%).

Carnival is the world's largest leisure travel group specializing in cruise operations. It owns multiple globally recognized cruise brands, serving millions of passengers yearly, offering all-inclusive vacation experiences covering accommodation, catering, entertainment, and shore excursions across global popular destinations.

Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.

CCL vs FMS — Head-to-Head

Bigger by revenue
CCL
CCL
1.2× larger
CCL
$6.3B
$5.5B
FMS
Growing faster (revenue YoY)
CCL
CCL
+6.9% gap
CCL
6.6%
-0.3%
FMS
Higher net margin
FMS
FMS
1.3% more per $
FMS
7.9%
6.6%
CCL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCL
CCL
FMS
FMS
Revenue
$6.3B
$5.5B
Net Profit
$421.0M
$434.2M
Gross Margin
27.4%
Operating Margin
11.6%
11.7%
Net Margin
6.6%
7.9%
Revenue YoY
6.6%
-0.3%
Net Profit YoY
38.9%
240.4%
EPS (diluted)
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCL
CCL
FMS
FMS
Q4 25
$6.3B
$5.5B
Q3 25
$8.2B
Q2 25
$6.3B
Q1 25
$5.8B
Q4 24
$5.9B
$5.5B
Q3 24
$7.9B
Q2 24
$5.8B
Q1 24
$5.4B
Net Profit
CCL
CCL
FMS
FMS
Q4 25
$421.0M
$434.2M
Q3 25
$1.9B
Q2 25
$565.0M
Q1 25
$-78.0M
Q4 24
$303.0M
$127.6M
Q3 24
$1.7B
Q2 24
$92.0M
Q1 24
$-214.0M
Gross Margin
CCL
CCL
FMS
FMS
Q4 25
27.4%
Q3 25
46.2%
Q2 25
38.6%
Q1 25
35.2%
Q4 24
35.5%
25.0%
Q3 24
45.5%
Q2 24
34.3%
Q1 24
31.5%
Operating Margin
CCL
CCL
FMS
FMS
Q4 25
11.6%
11.7%
Q3 25
27.9%
Q2 25
14.8%
Q1 25
9.3%
Q4 24
9.4%
5.1%
Q3 24
27.6%
Q2 24
9.7%
Q1 24
5.1%
Net Margin
CCL
CCL
FMS
FMS
Q4 25
6.6%
7.9%
Q3 25
22.7%
Q2 25
8.9%
Q1 25
-1.3%
Q4 24
5.1%
2.3%
Q3 24
22.0%
Q2 24
1.6%
Q1 24
-4.0%
EPS (diluted)
CCL
CCL
FMS
FMS
Q4 25
$0.33
Q3 25
$1.33
Q2 25
$0.42
Q1 25
$-0.06
Q4 24
$0.28
Q3 24
$1.26
Q2 24
$0.07
Q1 24
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCL
CCL
FMS
FMS
Cash + ST InvestmentsLiquidity on hand
$1.9B
$1.7B
Total DebtLower is stronger
$27.4B
Stockholders' EquityBook value
$12.3B
$15.4B
Total Assets
$51.7B
$33.5B
Debt / EquityLower = less leverage
2.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCL
CCL
FMS
FMS
Q4 25
$1.9B
$1.7B
Q3 25
$1.8B
Q2 25
$2.1B
Q1 25
$833.0M
Q4 24
$1.2B
$1.3B
Q3 24
$1.5B
Q2 24
$1.6B
Q1 24
$2.2B
Total Debt
CCL
CCL
FMS
FMS
Q4 25
$27.4B
Q3 25
$27.2B
Q2 25
$28.0B
Q1 25
$27.7B
Q4 24
$28.2B
Q3 24
$29.6B
Q2 24
$30.2B
Q1 24
$31.6B
Stockholders' Equity
CCL
CCL
FMS
FMS
Q4 25
$12.3B
$15.4B
Q3 25
$11.9B
Q2 25
$10.0B
Q1 25
$9.2B
Q4 24
$9.3B
$17.0B
Q3 24
$8.6B
Q2 24
$6.8B
Q1 24
$6.7B
Total Assets
CCL
CCL
FMS
FMS
Q4 25
$51.7B
$33.5B
Q3 25
$50.8B
Q2 25
$51.2B
Q1 25
$48.5B
Q4 24
$49.1B
$36.3B
Q3 24
$49.8B
Q2 24
$49.6B
Q1 24
$49.8B
Debt / Equity
CCL
CCL
FMS
FMS
Q4 25
2.23×
Q3 25
2.28×
Q2 25
2.79×
Q1 25
3.02×
Q4 24
3.05×
Q3 24
3.45×
Q2 24
4.43×
Q1 24
4.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCL
CCL
FMS
FMS
Operating Cash FlowLast quarter
$1.5B
$2.9B
Free Cash FlowOCF − Capex
$12.0M
FCF MarginFCF / Revenue
0.2%
Capex IntensityCapex / Revenue
23.8%
Cash ConversionOCF / Net Profit
3.61×
6.67×
TTM Free Cash FlowTrailing 4 quarters
$2.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCL
CCL
FMS
FMS
Q4 25
$1.5B
$2.9B
Q3 25
$1.4B
Q2 25
$2.4B
Q1 25
$925.0M
Q4 24
$911.0M
$2.6B
Q3 24
$1.2B
Q2 24
$2.0B
Q1 24
$1.8B
Free Cash Flow
CCL
CCL
FMS
FMS
Q4 25
$12.0M
Q3 25
$736.0M
Q2 25
$1.5B
Q1 25
$318.0M
Q4 24
$319.0M
Q3 24
$628.0M
Q2 24
$720.0M
Q1 24
$-370.0M
FCF Margin
CCL
CCL
FMS
FMS
Q4 25
0.2%
Q3 25
9.0%
Q2 25
24.4%
Q1 25
5.5%
Q4 24
5.4%
Q3 24
8.0%
Q2 24
12.5%
Q1 24
-6.8%
Capex Intensity
CCL
CCL
FMS
FMS
Q4 25
23.8%
Q3 25
7.9%
Q2 25
13.4%
Q1 25
10.4%
Q4 24
10.0%
Q3 24
7.3%
Q2 24
22.8%
Q1 24
39.5%
Cash Conversion
CCL
CCL
FMS
FMS
Q4 25
3.61×
6.67×
Q3 25
0.75×
Q2 25
4.23×
Q1 25
Q4 24
3.01×
20.20×
Q3 24
0.69×
Q2 24
22.16×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCL
CCL

Cruise Passenger Ticket$4.1B64%
Other$2.2B34%
Cruise$90.0M1%
Tour And Other$29.0M0%

FMS
FMS

Segment breakdown not available.

Related Comparisons